Business & Consumer Services » Business Services | Calmare Therapeutics Inc.

Calmare Therapeutics Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Net Income before Extraordinaries
3,004.10
2,672.20
3,410.90
3,678.10
3,828.60
Depreciation, Depletion & Amortization
14.50
11.10
17.50
16.50
16.50
Other Funds
249.30
359.40
779.90
682.70
919.30
Funds from Operations
2,740.20
2,301.60
2,613.50
2,978.90
2,892.80
Changes in Working Capital
1,368.80
735.10
1,551.80
1,448.10
1,655.50
Net Operating Cash Flow
1,371.40
1,566.40
1,061.70
1,530.90
1,237.30
Capital Expenditures
20.00
-
45.60
4.60
-
Net Investing Cash Flow
17.70
-
45.60
4.60
-
Issuance/Reduction of Debt, Net
1,435.00
1,549.10
225.50
1,214.50
1,200.00
Net Financing Cash Flow
1,435.00
1,549.10
1,056.00
1,579.50
1,200.00
Net Change in Cash
45.80
17.30
51.30
44.10
37.30
Free Cash Flow
1,391.40
1,566.40
1,107.30
1,535.40
1,237.30
Other Sources
2.30
-
-
-
-
Change in Capital Stock
-
-
830.50
365.00
-

About Calmare Therapeutics

View Profile
Address
1375 Kings Highway East
Fairfield Connecticut 06824
United States
Employees -
Website http://www.calmaretherapeutics.com
Updated 07/08/2019
Calmare Therapeutics, Inc. is a medical device company, which develops and distributes products and technologies for chronic neuropathic pain and wound care affliction patients. Its product device, Calmare Pain Therepy Device, is non-invasive and non-addictive modality that treats chronic, neuropathic pain. The company was founded in 1968 and is headquartered in Fairfield, CT.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.